Compare ADMA Biologics Inc (ADMA) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Amylx Pharmaceuticals Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). The key difference: Amylx Pharmaceuticals Inc is the larger of the two by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | AMLX | |
|---|---|---|
Market Cap | $2.22B | $2.64B |
Sector | Health | Health |
52-Week High | $20.38 | $24.19 |
52-Week Low | $7.60 | $7.82 |
Enterprise Value | $2.29B | $2.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
